EDITORS:    New York Times editors are CONSIDERING these stories for Tuesday's Page 1:    &UR; WASHINGTON &LR;  (``w'' code)    CLINTON-STARR (Washington) _ Deadline at 4:30 p.m. today for the White House to respond to Kenneth Starr's request for taking an executive privilege dispute directly to the Supreme Court.
&UR; FINANCIAL &LR;  (``f'' code)    AHP-MONSANTO (Undated) _ American Home Products acquires Monsanto for about $34.4 billion in stock, creating one of the world's largest makers of pharmaceuticals, seeds and herbicides.
The acquisition by American Home adds Monsanto's arthritis drugs, including at least one potential blockbuster, to American Home's Advil painkiller and Premarin hormone-replacement therapy.
&UR; SCIENCE &LR;  (``a'' code)    SCI-MIR (Undated) _ Visits to the Russian space station Mir by American space shuttle crews are about to end.
&UR; NATIONAL GENERAL &LR;  (``a'' code)    PHILLY-TRANSIT-STRIKE (Washington) _ Philadelphia transit workers make good on their strike threat and walk off their jobs at noon, bringing public transportation to a halt in a city that can ill afford a protracted labor dispute.
After being a focus of U.S. manned space activity for the past three years, stays on Mir are about to join Gemini capsules and Saturn rockets as historical artifacts of the nation's space program.
The shuttle Discovery is scheduled to dock with Mir later this week and retrieve astronaut Andrew Thomas, the last of seven American to work on the station in the last three years.
Monsanto, which spun off its chemicals business last year to focus on genetically engineered crops and agricultural products, agreed three weeks ago to buy DeKalb Genetics and Delta and Pine Land for $4.1 billion.
HMO-LOBBY (Washington) _ A look at the high-stakes lobbying surrounding the HMO debate as House Republicans prepare a final draft of a bill and Democrats step up the pressure, looking to score political points.
It was tagged ``America's other drug problem'' when researchers consistently found it responsible for 10 to 25 percent of hospital and nursing home admissions studied.
